Tocilizumab, an anti-IL-6 receptor antibody, to treat COVID-19-related respiratory failure: a case report - Michot, J.-M.; Albiges, L.; Chaput, N.; Saada, V.; Pommeret, F.; Griscelli, F.; Balleyguier, C.; Besse, B.; Marabelle, A.; Netzer, F.; Merad, M.; Robert, C.; et al. (Annals of oncology, 2020)
Keywords: Adult; Antibodies, Monoclonal, Humanized - therapeutic use; Autoantibodies - therapeutic use; Betacoronavirus; Coronavirus Infections - complications; Coronavirus Infections - diagnostic imaging; Coronavirus Infections - drug therapy; COVID-19; Humans; Letter to the Editor; Male; Pandemics; Pneumonia, Viral - complications; Pneumonia, Viral - diagnostic imaging; Pneumonia, Viral - drug therapy; Receptors, Interleukin-6 - antagonists & inhibitors; Respiratory Insufficiency - diagnostic imaging; Respiratory Insufficiency - drug therapy; Respiratory Insufficiency - etiology; SARS-CoV-2; Treatment Outcome